Dr. Brian Procter: COVID-19 pandemic treatment record

Dr. Brian Procter's early 2020 evidence-based treatment protocol was shown to have excellent outcomes. Widespread use of Dr. Procter's protocol would have ended the pandemic much sooner. See all physicians.
c19early.org
COVID-19 TREATMENT RECORD — Dr. Procter vs. Dr. Fauci
RECOMMENDED
TREATMENTS
12 of 14
early recommendations
reduce risk
55 - 94% efficacy
$4.06 / treatment
PREDICTED
OUTCOME
3 months
547 deaths
$27 billion
RECOMMENDED
TREATMENTS
0 of 3
early recommendations
reduce risk
-26% efficacy
$4,060 / treatment
ACTUAL
OUTCOME
3 years
20 million deaths
$20 trillion
Dr. Brian Procter
CENSORED
Dr. Anthony Fauci
10+ AWARDS
$0 $1,000 $2,000+ -25+% 0% 25% 50% Treatment cost (US$) Efficacy vs. cost: Dr. Procter's protocol vs. USA approved treatments +59 more high-profit drugs PPIs -46% BMS mAbs -36% Darunavir -34% Acetaminophen -28% Cenicriviroc -28% Cannabidiol Lufotrelvir Losartan Sargramostim Dexamethasone Lopinavir/ritonavir Ravulizumab Remdesivir Conv. Plasma Sarilumab Ibuprofen Masks Molnupiravir mutagenic/teratogenic Aspirin Tocilizumab Favipiravir Paxlovid Ratutrelvir Famotidine Vitamin C Sotrovimab Colchicine TMPRSS2 i.. NAC Amubarvimab/r.. Vilobelimab Azvudine Budesonide Probiotics HCQ Ensitrelvir Tixagevimab/c.. Zinc Vitamin B12 Antiandro.. Sleep Metformin Vitamin A Melatonin Bebtelovimab Nitric Oxide Quercetin H1RAs CPC Vitamin D H. Peroxide Exercise Fluvox. Sunlight Curcumin NaHCO₃ N. Sativa Casirivimab/i.. Bamlanivimab/e.. Ensovibep PVP-I pH+ Diet Regdanvimab Thermotherapy Ivermectin Dr. Procter US official Lowerrisk Higherrisk c19early.org August 2026 Dr. Procter's protocol combines low-cost evidence-basedtreatments with complementary and synergistic effects. Efficacyand cost are favorable compared with official treatments.c19early analyzes over 6,600 studies for 226 treatments.
$0 $1,000 $2,000+ -20+% 0% 25% 50% Treatment cost (US$) Efficacy vs. cost: Dr. Procter's protocol vs. USA approved +59 more high-profit drugs PPIs -46% BMS mAbs -36% Acetaminophen -28% Cenicriviroc -28% CBD -23% Lufotrelvir -22% Losartan Sargramostim Dexame.. Lopinav.. Vit. B9 Ravulizumab Remdesivir C. Plasma Sarilumab Ibuprofen Masks Molnupiravir mutagenic/teratogenic Aspirin Tocilizumab Favipir.. Paxlovid Ratutrelvir Famotidine Vitamin C Sotrovimab Colchicine TMPRSS2 i.. NAC Amubarvimab/r.. Vilobelimab Azvudine Budesonide Probiotics HCQ Tixagev.. Zinc Vitamin B12 Antiandro.. Sleep Metformin Vitamin A Melatonin Bebtelovimab Nitric Oxide Quercetin H1RAs CPC Vitamin D H. Peroxide Exercise Fluvox. Sunlight Curcumin NaHCO₃ N. Sativa Casirivim.. Bamlan.. Ensovibep PVP-I pH+ Diet Regdanvimab Thermotherapy Ivermectin Dr. Procter US official Lowerrisk Higherrisk c19early.org August 2026 Dr. Procter's protocol combineslow-cost evidence-basedtreatments. c19early analyzes over6,600 studies for 226 treatments.
c19early.org
Dr. Procter developed an evidence-based protocol for early COVID-19 treatment. Average treatment cost: $4.06. Predicted combined efficacy: 55%-94%.
CENSORED
Reference Studies Confirmed
beneficial
Outcomes Confidence
HydroxychloroquineHCQ Early aggressive outpati..Early aggres..1 424 March 20202 p < 0.0000001
Vitamin DVitamin D MFM Coronavirus (COVID-1..MFM Coronavi..3 138 October 20204 p < 0.0000001
IvermectinIvermectin MFM Coronavirus (COVID-1..MFM Coronavi..3 106 August 20205 p < 0.0000001
Vitamin CVitamin C McKinney Family Medicine..McKinney Fam..6 72 September 20207 p < 0.0000001
ZincZinc Early aggressive outpati..Early aggres..1 41 July 20208 p = 0.00000012
ProbioticsProbiotics MFM Coronavirus (COVID-1..MFM Coronavi..3 29 March 20219 p = 0.00000044
N-acetylcysteineN-acetylcys.. MFM Coronavirus (COVID-1..MFM Coronavi..3 26 February 202110 p = 0.000002
BudesonideBudesonide MFM Coronavirus (COVID-1..MFM Coronavi..3 15 September 202111 p = 0.000003
Antihistamine H1RAH1RA MFM Coronavirus (COVID-1..MFM Coronavi..3 17 December 202012 p = 0.000052
AspirinAspirin Early aggressive outpati..Early aggres..1 79 Positive, small benefit13 p = 0.015
Vitamin B12Vitamin B12 MFM Coronavirus (COVID-1..MFM Coronavi..3 4 February 202214 p = 0.023
AzithromycinAzithromycin Early aggressive outpati..Early aggres..1 30 Positive, small benefit15 p = 0.081
CannabidiolCannabidiol Procter video (anti-infl..Procter vide..16 12 Increased risk17 p = 0.39
LosartanLosartan Early aggressive outpati..Early aggres..1 6 Increased risk18 p = 0.59
References